Free tool
Stocks above their 200-day average
We cover 58 companies trading above their own 200-day average. The median market value in the group is $70.17M. Across the group, the median move over the past trading day is +0.91%. 100% of the 58 with a 200-day average trade above it. Price change over the past year runs from −33.8% to +105.9% across the middle 80 percent of the group, with a median of +23.7%.
Other lists in this group
Table
58 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | $1.07T | Mega cap | +73.55% | Oct 29, 2026 |
| LLY | Eli Lilly and Company | $1.06T | Mega cap | +62.80% | Oct 29, 2026 |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% | Oct 13, 2026 |
| JNJ.DE | Johnson & Johnson | $651.71B | Mega cap | +58.93% | Oct 13, 2026 |
| 4AB.DE | AbbVie Inc. | $471.29B | Mega cap | +32.34% | Oct 29, 2026 |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +29.36% | Oct 29, 2026 |
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% | Oct 29, 2026 |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% | Oct 29, 2026 |
| NOT.DE | Novartis AG | $300.14B | Mega cap | +28.89% | Oct 27, 2026 |
| NVS | Novartis AG | $299.44B | Mega cap | +27.93% | Oct 27, 2026 |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% | Nov 3, 2026 |
| AMG.DE | Amgen Inc. | $237.76B | Mega cap | +60.12% | Nov 3, 2026 |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% | Oct 21, 2026 |
| TN8.DE | Thermo Fisher Scientific Inc. | $234.00B | Mega cap | +29.67% | Oct 21, 2026 |
| NVO.WA | Novo Nordisk A/S | $212.23B | Mega cap | −9.22% | Nov 4, 2026 |
| NOVO-B.CO | Novo Nordisk A/S | $210.20B | Mega cap | −11.26% | Nov 4, 2026 |
| NOV.DE | Novo Nordisk A/S | $209.27B | Mega cap | +15.22% | Nov 4, 2026 |
| NVO | Novo Nordisk A/S | $208.63B | Mega cap | −13.32% | Nov 4, 2026 |
| ABL.DE | Abbott Laboratories | $200.44B | Mega cap | −10.02% | Oct 14, 2026 |
| NANOFH.HE | Nanoform Finland Oyj | $95.78M | Micro cap | +15.66% | Nov 11, 2026 |
| ATRA | Atara Biotherapeutics, Inc. | $94.15M | Micro cap | −24.05% | Nov 12, 2026 |
| NANOFS.ST | Nanoform Finland Oyj | $93.63M | Micro cap | +19.56% | Nov 11, 2026 |
| ECOR | electroCore, Inc. | $93.31M | Micro cap | +86.49% | Nov 4, 2026 |
| ICCC | ImmuCell Corporation | $91.00M | Micro cap | +64.26% | Nov 12, 2026 |
| ACET | Adicet Bio, Inc. | $83.79M | Micro cap | −26.01% | Nov 11, 2026 |
| OSTX | OS Therapies Incorporated | $76.68M | Micro cap | −34.00% | Nov 16, 2026 |
| MNOV | MediciNova, Inc. | $72.85M | Micro cap | +10.45% | Nov 12, 2026 |
| 4875.T | MediciNova, Inc. | $71.04M | Micro cap | +11.17% | Nov 12, 2026 |
| ZLNA.OL | Zelluna ASA | $70.31M | Micro cap | +56.57% | Nov 5, 2026 |
| PMVP | PMV Pharmaceuticals, Inc. | $70.03M | Micro cap | −7.75% | Nov 16, 2026 |
| INMB | INmune Bio Inc. | $67.86M | Micro cap | +19.56% | Oct 29, 2026 |
| TLPH | Talphera, Inc. | $65.40M | Micro cap | +133.33% | Nov 11, 2026 |
| MYO | Myomo, Inc. | $60.60M | Micro cap | +36.61% | Nov 9, 2026 |
| INKT | MiNK Therapeutics, Inc. | $60.16M | Micro cap | −26.22% | Nov 12, 2026 |
| SCYX | SCYNEXIS, Inc. | $56.41M | Micro cap | +579.04% | Nov 4, 2026 |
| HOWL | Werewolf Therapeutics, Inc. | $48.05M | Micro cap | −25.65% | Oct 30, 2026 |
| MLSS | Milestone Scientific Inc. | $47.87M | Micro cap | −10.10% | Nov 12, 2026 |
| ALGS | Aligos Therapeutics, Inc. | $46.65M | Micro cap | −33.72% | Nov 5, 2026 |
| ELUT | Elutia Inc. | $44.29M | Micro cap | −54.75% | Nov 12, 2026 |
| NEPH | Nephros, Inc. | $43.98M | Micro cap | 0.00% | Nov 5, 2026 |
| ONCIN.OL | Oncoinvent ASA | $43.71M | Micro cap | +10.90% | Aug 27, 2026 |
| IVACC.ST | Intervacc AB (publ) | $38.50M | Micro cap | +4.78% | Nov 12, 2026 |
| HBIO | Harvard Bioscience, Inc. | $34.83M | Micro cap | +44.34% | Nov 5, 2026 |
| KYNB | Kyntra Bio, Inc. | $32.82M | Micro cap | −22.66% | Nov 9, 2026 |
| RMTI | Rockwell Medical, Inc. | $31.90M | Micro cap | +438.44% | Nov 11, 2026 |
| QNCX | Quince Therapeutics, Inc. | $31.84M | Micro cap | +100.71% | Nov 12, 2026 |
| INTEG-B.ST | Integrum AB (publ) | $24.72M | Micro cap | −79.55% | Sep 3, 2026 |
| LABS.TO | MediPharm Labs Corp. | $23.16M | Micro cap | +6.67% | Nov 12, 2026 |
| BFRI | Biofrontera Inc. | $22.72M | Micro cap | +77.91% | Nov 11, 2026 |
| LFWD | Lifeward Ltd. | $20.93M | Micro cap | +0.03% | Nov 12, 2026 |
| BIVI | BioVie Inc. | $17.83M | Micro cap | +30.25% | Nov 9, 2026 |
| LUCY | Lucyd, Inc | $9.73M | Micro cap | −42.05% | Nov 12, 2026 |
| SKYE | Skye Bioscience, Inc. | $8.92M | Micro cap | −41.62% | Nov 9, 2026 |
| ICCM | IceCure Medical Ltd | $7.85M | Micro cap | +132.49% | Nov 18, 2026 |
| INM | InMed Pharmaceuticals Inc. | $7.64M | Micro cap | −36.44% | Sep 23, 2026 |
| CSCI.TO | COSCIENS Biopharma Inc. | $5.24M | Micro cap | +60.79% | Nov 10, 2026 |
| XAIR | Beyond Air, Inc. | $4.89M | Micro cap | +117.98% | Nov 10, 2026 |
| TNON | Tenon Medical, Inc. | $3.48M | Micro cap | +297.71% | Nov 12, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.